Inhibikase Therapeutics, Inc. (IKT)

Number of records: 9
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
31-May-22 10:16 AM
View: 
Werner Milton H.
President and CEO
Director
10% Owner
Inhibikase Therapeutics, Inc. (IKT) 27-May-22Private Purchase 5,000$0.98$4,880.00< 1%
5.33M to 5.33M
23-May-22 4:57 PM
View: 
Werner Milton H.
President and CEO
Director
10% Owner
Inhibikase Therapeutics, Inc. (IKT) 20-May-22Private Purchase 10,000$0.60$6,000.00< 1%
5.32M to 5.33M
23-May-22 4:54 PM
View: 
Frattaroli Joseph
Chief Financial Officer
Inhibikase Therapeutics, Inc. (IKT) 19-May-22Private Purchase 3,948$0.64$2,542.519%
44.14K to 48.09K
04-Jan-22 9:25 PM
View: 
Werner Milton H.
President and CEO
Director
10% Owner
Inhibikase Therapeutics, Inc. (IKT) 03-Jan-22Option Exercise 21,853$2.02$44,143.10< 1%
5.29M to 5.32M
19-Nov-21 8:13 AM
View: 
Werner Milton H.
President and CEO
Director
10% Owner
Inhibikase Therapeutics, Inc. (IKT) 17-Nov-21Market Purchase 23,589$1.97$46,558.10< 1%
5.29M to 5.32M
(4%)
19-Aug-21 7:46 AM
View: 
Werner Milton H.
President and CEO
Director
10% Owner
Inhibikase Therapeutics, Inc. (IKT) 17-Aug-21Option Exercise 21,853$2.02$44,143.10< 1%
5.27M to 5.29M
(3%)
18-May-21 5:46 PM
View: 
Werner Milton H.
President and CEO
Director
10% Owner
Inhibikase Therapeutics, Inc. (IKT) 14-May-21Payment of Exercise 16,918$4.59$77,653.60(< 1%)
5.29M to 5.27M
18-May-21 5:46 PM
View: 
Werner Milton H.
President and CEO
Director
10% Owner
Inhibikase Therapeutics, Inc. (IKT) 14-May-21Option Exercise 43,707$0.38$16,608.70< 1%
5.24M to 5.29M
29-Dec-20 9:52 PM
View: 
Frattaroli Joseph
Chief Financial Officer
Inhibikase Therapeutics, Inc. (IKT) 28-Dec-20Conversion 44,143$10.00$441,430.00100%
0 to 44.14K